Generic user fee survey
Generic Pharmaceutical Association is surveying members' on user fees for ANDAs. Companies are being asked whether they would accept fees under any condition. The survey, which is due back Feb. 4, also asks firms to describe "the benefits to the generic industry that you would want to see accompany a user fee if one were to be implemented by Congress"...
You may also be interested in...
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.